当前位置:产品中心 > 抗体 > Biosimilar抗体 > 细胞因子 > Anti-Mouse_PD1xVEGF mIgG1 Antibody
Anti-Mouse_PD1xVEGF mIgG1 Antibody
基本信息

产品编号:GM-87947MAB

产品名称:Anti-Mouse_PD1xVEGF mIgG1 Antibody

目录价:询价

产品配图.jpg


规格货号

GM-87947MAB-1mg / 1 mg

GM-87947MAB-5mg / 5 mg

GM-87947MAB-25mg / 25 mg

GM-87947MAB-50mg / 50 mg

GM-87947MAB-100mg / 100 mg



产品简介

Expression System        CHO

Aggregation                    < 5% as determined by SEC-HPLC

Purity                              > 95% as determined by SDS-PAGE

Endotoxin                       < 1 EU/mg, determined by LAL gel clotting assay

Sterility                            0.2 μm Filtered

Target                              VEGF&PD1

Clone                              PD1: CD279

Alternative Names          VEGF: VPF; MVCD1; L-VEGF

Source/Isotype               Monoclonal mouse IgG1 D265A, Kappa

Application                     /

Description                      PD-1/VEGF Bispesific Antibody is a novel cancer immunotherapy drug that can target both PD-1 and VEGF. It blocks the interaction between PD-1 and PD-L1/PD-L2. The bispecific antibody can specifically bind to VEGFA and PD-1, selectively relieve the immune suppression caused by VEGFA and PD-1 in the body, and inhibit tumor-induced angiogenesis.

Formulation                      phosphate-buffered solution, pH 7.4.


数据展示

image.png


image.png

当前位置:产品中心 > 抗体 > Biosimilar抗体 > Anti-Mouse_PD1xVEGF mIgG1 Antibody

Anti-Mouse_PD1xVEGF mIgG1 Antibody
基本信息

产品编号:GM-87947MAB

产品名称:Anti-Mouse_PD1xVEGF mIgG1 Antibody

目录价:询价

产品配图.jpg


规格货号

GM-87947MAB-1mg / 1 mg

GM-87947MAB-5mg / 5 mg

GM-87947MAB-25mg / 25 mg

GM-87947MAB-50mg / 50 mg

GM-87947MAB-100mg / 100 mg



产品简介

Expression System        CHO

Aggregation                    < 5% as determined by SEC-HPLC

Purity                              > 95% as determined by SDS-PAGE

Endotoxin                       < 1 EU/mg, determined by LAL gel clotting assay

Sterility                            0.2 μm Filtered

Target                              VEGF&PD1

Clone                              PD1: CD279

Alternative Names          VEGF: VPF; MVCD1; L-VEGF

Source/Isotype               Monoclonal mouse IgG1 D265A, Kappa

Application                     /

Description                      PD-1/VEGF Bispesific Antibody is a novel cancer immunotherapy drug that can target both PD-1 and VEGF. It blocks the interaction between PD-1 and PD-L1/PD-L2. The bispecific antibody can specifically bind to VEGFA and PD-1, selectively relieve the immune suppression caused by VEGFA and PD-1 in the body, and inhibit tumor-induced angiogenesis.

Formulation                      phosphate-buffered solution, pH 7.4.


数据展示

image.png


image.png

Tel: 400-627-9288
留言咨询
重置
提交
客服
微信
电话
留言
留言咨询
重置
提交